Search Prime Grants

HT94252310246

Project Grant

Overview

Grant Description
Scalable manufacturing and toxicity testing of intranasal M2SR influenza vaccine.
Awardee
Flugen
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Madison, Wisconsin 537111084 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the total obligations have decreased 50% from $11,199,994 to $5,599,997.
Flugen was awarded Scalable Manufacturing Toxicity Testing of Intranasal M2SR Influenza Vaccine Project Grant HT94252310246 worth $5,599,997 from Defense Health Agency in April 2023 with work to be completed primarily in Madison Wisconsin United States. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 4/5/23

Period of Performance
4/1/23
Start Date
3/31/26
End Date
92.0% Complete

Funding Split
$5.6M
Federal Obligation
$0.0
Non-Federal Obligation
$5.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310246

Additional Detail

Award ID FAIN
HT94252310246
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
M9FHAR3RBML5
Awardee CAGE
54YS4
Performance District
Not Applicable
Modified: 4/5/23